Denmark takes decisive step towards introducing bar codes on medicine in 2019

The Danish pharmaceutical industry has received a new European approval, which means that Denmark is well on its way to introducing manufacturer-paid bar codes on medicine that the EU requires to be introduced before February 2019, and which has cost Novo an investment of more than DKK 100 million (USD 16.6 million).

A real viagra pill from Pfizer (in the middle) in a pile of fakes. The EU wants to remove any doubt about counterfeit medicine with a new bar code system, and Denmark is well on its way to introduce it. Photo: Pfizer

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Her er de vigtigste nyheder fra MedWatch i uge 38

En "digital transformation" i Novo Nordisks F&U-afdeling, som koster 400 medarbejdere jobbet, stjal fokus i uge 38, hvor Zealand Pharma ramte plet i et afgørende fase 3-studie og Coloplast holdt kapitalmarkedsdag. MedWatch giver dig her overblikket over ugens vigtigste begivenheder.

CHMP får ny, tysk formand

Ved sit septembermøde har EU's ekspertkomité på ibrugtagning af nye lægemidler, CHMP, valgt en ny formand for de næste tre år, ny næstformand skal vælges i næste måned.

Related articles